By Dani Kass ( June 15, 2016, 2:06 PM EDT) -- Janssen Biotech Inc. on Tuesday accused a General Electric unit in Utah federal court of infringing its patent for a cell culture media used to grow Inflectra, Celltrion Healthcare Co. and Hospira Inc.'s biosimilar of Janssen's blockbuster immunosuppressant Remicade....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.